Effect of maternal intrahepatic cholestasis on fetal steroid metabolism.
Estriol, estriol sulfate, progesterone, and 17 neutral steroid sulfates, including estriol precursors and progesterone metabolites, were determined in 27 cord plasma samples collected after pregnancies complicated by intrahepatic cholestasis of the mother. The levels of these steroids were compared with those in the cord plasma of 42 healthy controls. In the cord plasma, the steroid profile after pregnancies complicated by maternal intrahepatic cholestasis differed greatly from that seen after uncomplicated pregnancy. Two main differences were found. In the disulfate fraction, the concentrations of two pregnanediol isomers, 5alpha-pregnane-3alpha,20alpha-diol and 5beta-pregnane-3alpha,20alpha-diol, were high after cholestasis. Other investigators have shown that, as a result of cholestasis, these pregnanediol sulfates circulate in greatly elevated amounts in the maternal plasma. Our results indicate that in cholestasis these steroids cross the placenta into the fetal compartment, where they circulate in elevated amounts as disulfates. Secondly, the concentrations of several steroid sulfates known to be synthesized by the fetus were significantly lower in the cholestasis group than in the healthy controls. This was especially true of 16alpha-hydroxydehydroepiandrosterone sulfate and 16alpha-hydroxypregnenolone sulfate. These results suggest that, in pregnancies complicated by maternal intrahepatic cholestasis, impairment of fetal steroid synthesis, and especially of 16alpha-hydroxylation, occurs in the fetal compartment.Thus, the changes in maternal steroid metabolism caused by cholestasis are reflected in the steroid profile of the fetoplacental circulation. Furthermore, maternal intrahepatic cholestasis may result in the production of some substance which crosses the placenta and affects fetal steroid metabolism.
D006907:17-alpha-Hydroxypregnenolone / Q000096:biosynthesis / Q000097:blood; D000737:Androstenols / Q000097:blood; D000738:Androsterone / Q000097:blood; D001724:Birth Weight; D002779:Cholestasis / Q000097:blood / Q000378:metabolism*; D003687:Dehydroepiandrosterone / Q000096:biosynthesis; D004964:Estriol / Q000097:blood; D005260:Female; D005333:Fetus / Q000378:metabolism*; D005865:Gestational Age; D006801:Humans; D006900:Hydroxylation; D008297:Male; D008431:Maternal-Fetal Exchange; D010920:Placenta / Q000378:metabolism; D011247:Pregnancy; D011248:Pregnancy Complications; D011276:Pregnanediol / Q000097:blood; D011279:Pregnanetriol / Q000097:blood; D011284:Pregnenolone / Q000097:blood; D011374:Progesterone / Q000097:blood; D013256:Steroids / Q000378:metabolism*; D014470:Umbilical Cord
D000737:Androstenols; D013256:Steroids; D011279:Pregnanetriol; D006907:17-alpha-Hydroxypregnenolone; D003687:Dehydroepiandrosterone; D011374:Progesterone; D011284:Pregnenolone; D000738:Androsterone; D004964:Estriol; D011276:Pregnanediol